DWTX fundamentals
An in-depth look to Dogwood Therapeutics, Inc. operating, investing, and financing activities
DWTX free cash flow for Q3 24 is -910.14 k USD. For 2023, DWTX free cash flow was -4.87 M USD and operating cash flow was -4.87 M USD.
Q2 '19
Q3 '19
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '19
Q3 '19
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM